Zoetis Inc. is a leading global animal health company that focuses on developing, manufacturing, and marketing a wide range of veterinary vaccines, medicines, and diagnostics for both livestock and companion animals. The company was founded in 2013 as a spin-off from Pfizer Inc., and it has since become the largest standalone animal health company in the world.
Zoetis traces its roots back to Pfizer's animal health division, which was established in the 1950s. Over the years, Pfizer's animal health division grew through acquisitions and research and development, becoming a major player in the animal health industry. In 2013, Pfizer decided to spin off its animal health division into a separate company, and Zoetis was born.
The company's product portfolio includes a wide range of animal health products, including vaccines for preventing and treating diseases, medicines for controlling parasites, and diagnostics for detecting and monitoring health conditions in animals. Zoetis serves customers in more than 100 countries and operates in both developed and emerging markets.
Zoetis is listed on the New York Stock Exchange (NYSE) under the ticker symbol "ZTS." It is one of the few companies solely focused on animal health, which gives it a unique position in the market. The company's strong research and development capabilities have allowed it to introduce innovative products that address the specific health needs of different species of animals.
As a global animal health leader, Zoetis is committed to improving the health and well-being of animals and, consequently, the people who care for them. The company's products are essential for maintaining the health of livestock, ensuring a safe food supply, and supporting the health and happiness of pets worldwide. Zoetis continues to invest in research and development to bring new and improved solutions to veterinarians, livestock producers, and pet owners, further strengthening its position as a key player in the animal health industry.